Skip Navigation

News & Resources


Subscribe to NHLBI Press Releases
September 12, 2016

Researchers Discover New Genetic Markers for Blood Pressure

WHAT: A team of researchers led by scientists from the Framingham Heart Study has discovered 31 new genetic markers it says are associated with blood pressure. The large-scale study provides new insight into the genetic underpinnings of high blood pressure and researchers say it could lead to better ways to treat the disease. Their study was published in Nature Genetics.

Subscribe to NHLBI In The News
September 26, 2016 : HealthDay

Researchers are reporting new evidence that an increase in the amount of belly fat, especially “hidden fat” deep in the gut, is associated with a higher risk of developing heart disease.  The study also demonstrated that the density of stomach fat is as important as how much fat you have. In particular, the researchers found that lower density abdominal fat was associated with a higher risk for heart disease.  The six-year study included more than 1,000 adults.  It was published in the Journal of the American College of Cardiology and funded by the National Heart, Lung, and Blood Institute.

September 26, 2016 : Cardiovascular Business

Researchers are reporting new evidence that drinking tea is good for the heart.  In the study, the researchers evaluated more than 6,000 participants from the Multi-Ethnic Study of Atherosclerosis (MESA), which is sponsored by the National Heart, Lung, and Blood Institute (NHLBI). They found that adults who drank at least one cup of tea per day had a slower progression of coronary artery calcium (a marker for subclinical heart disease) and a 29 percent lower risk of cardiovascular events, including heart attack and stroke, compared to adults who did not drink tea.  The study, funded by NHLBI, was published in The American Journal of Medicine

October 24, 2016 to October 25, 2016
Natcher Conference Center(Building 45) Bethesda, Maryland
The conference Unraveling Vascular Inflammation: From Immunology to Imaging 2016, sponsored by the National Heart, Lung and Blood Institutes (NHLBI) of the National Institutes of Health (NIH), seeks to convene scientists, researchers and physicians from around the world with an interest in immunology, human translational studies involving cardiovascular imaging and quantification. Hosted at the NIH campus, in Bethesda, MD, October 24 and 25, the day and a half conference will feature three keynote speakers (immunology, human inflammation and imaging), poster session and competition (including cash poster award and A High-Yield Series of Imaging Talks, a rapid fire series of 10 minutes talks by leading imaging scientists in the field.
November 1, 2016 to November 3, 2016
NHLBI Innovation Conference NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts the NHLBI Innovation Conference to connect NHLBI-funded companies with investors, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries.